Review of ceftaroline fosamil microbiology: integrated FOCUS studies.

  title={Review of ceftaroline fosamil microbiology: integrated FOCUS studies.},
  author={Ian A. Critchley and Paul B Eckburg and Alena Jandourek and Donald Biek and Hillel David Friedland and Dirk A Thye},
  journal={The Journal of antimicrobial chemotherapy},
  volume={66 Suppl 3},
Ceftaroline fosamil, the prodrug form of ceftaroline, is a novel broad-spectrum parenteral cephalosporin that exhibits antibacterial activity against typical respiratory pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus and common Gram-negative pathogens. In particular, ceftaroline has activity against resistant Gram-positive cocci, including penicillin- and multidrug-resistant S. pneumoniae, as well as methicillin-resistant S. aureus. The activity of… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 20 extracted citations


Publications referenced by this paper.
Showing 1-10 of 25 references

Microbiological outcomes of 2 multicenter phase 3 clinical trials of ceftaroline in community-acquired bacterial pneumonia

  • IA Critchley, HD Friedland, P Eckburg
  • Abstracts of the Annual American Thoracic Society…
  • 2010

Similar Papers

Loading similar papers…